Abstract

The secretion of extracellular membrane vesicles (EMVs) is a common phenomenon that occurs in archaea, bacteria, and mammalian cells. The EMVs of bacteria play important roles in their virulence, biogenesis mechanisms, and host cell interactions. Bacterial EMVs have recently become the focus of attention because of their potential as highly effective vaccines that cause few side effects. Here, we isolated the EMVs of Streptococcus pneumoniae and examined their potential as new vaccine candidates. Although the S. pneumoniae bacteria were highly pathogenic in a mouse model, the EMVs purified from these bacteria showed low pathological activity both in cell culture and in mice. When mice were injected intraperitoneally with S. pneumoniae EMVs and then challenged, they were protected from both the homologous strain and another pathogenic serotype of S. pneumoniae. We also identified a number of proteins that may have immunogenic activity and may be responsible for the immune responses by the hosts. These results suggest that S. pneumoniae EMVs or their individual immunogenic antigens may be useful as new vaccine agents.

Highlights

  • Streptococcus pneumonia is an alpha-hemolytic Gram-positive encapsulated aerobic diplococcus bacterium that is the main causative pathogen of community-acquired respiratory tract infections

  • Transmission Electron Microscope (TEM) examination confirmed the presence of S. pneumoniae BAA-255 extracellular membrane vesicles (EMVs)

  • The present study aimed to examine the potential of bacterial EMVs as vaccines

Read more

Summary

Introduction

Streptococcus pneumonia is an alpha-hemolytic Gram-positive encapsulated aerobic diplococcus bacterium that is the main causative pathogen of community-acquired respiratory tract infections. S. pneumoniae has been isolated from various animals, including guinea pigs, cats, horses, dogs, and gorillas. These animals all exhibit S. pneumoniae-related clinical symptoms [4]. These S. pneumonia-infected animal hosts may serve as an extrahuman reservoir from which the pathogen can be transmitted to humans. A recent review reported that failure of pneumococcal conjugate vaccines is rare, but irrespective of vaccine or schedule [5]. This may lead us to evaluate EMVs of S. pneumoniae for vaccine candidates

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call